RXST RxSight, Inc.
Healthcare$5.99-1.56%ClosedMarket Cap: $248.0M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
1.95
EV/EBITDA
-4.82
DCF Value
$-238.36
FCF Yield
-8.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
77.0%
Operating Margin
-43.4%
Net Margin
-36.6%
ROE
-17.0%
ROA
-15.3%
ROIC
-19.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $30.9M | 76.1% | $-17.8M | $-15.9M | $— | — |
| Q4 null | $32.6M | 77.5% | $-11.3M | $-9.2M | $— | — |
| FY null | $134.5M | 76.6% | $-48.2M | $-38.9M | $— | — |
| Q3 null | $30.3M | 79.9% | $-12.2M | $-9.8M | $— | — |
| Q2 null | $33.6M | 74.9% | $-14.0M | $-11.8M | $— | — |
| Q1 null | $37.9M | 74.8% | $-10.7M | $-8.2M | $— | — |
| Q4 null | $40.2M | 71.6% | $-8.6M | $-5.9M | $— | — |
| FY null | $139.9M | 70.7% | $-36.9M | $-27.5M | $— | — |
| Q3 null | $45.4M | 55.5% | $-9.2M | $-6.3M | $— | — |
| Q2 null | $34.9M | 69.5% | $-8.3M | $-6.1M | $— | — |
| Q1 null | $29.5M | 70.1% | $-10.7M | $-9.1M | $— | — |
| Q4 2023 | $28.6M | 61.8% | $-10.9M | $-9.2M | $-0.26 | — |